英国与澳大利亚前瞻性队列中黑色素瘤多基因风险评分的独立评估
研究在英国生物银行(UKB,n=395647,1651例)和墨尔本协作队列研究(MCCS,n=4765,303例)中评估三种多基因风险评分(PRS)对侵袭性黑色素瘤的预测。仅基于年龄和性别的预测低估发病风险(UKB E/O=0·65,MCCS E/O=0·63),PRS50校正后UKB校准改善(E/O=0·91),PRS68与PRS50校正风险的判别能力高于年龄性别模型。
要点
- 仅按年龄和性别预测的绝对风险低估黑色素瘤发病率,UKB的E/O=0·65、MCCS的E/O=0·63。
- UKB中PRS50校正后校准改善,E/O=0·91(95%CI 0·87-0·95)。
- PRS68与PRS50校正风险的判别能力高于年龄性别模型(ΔAUC 0·07-0·10,P<0·0001)。
核心结论
- 基于更大、更多样化荟萃分析得出的PRS较早期PRS改善风险预测,可能有助于按不同风险水平制定黑色素瘤预防和早期发现策略。
- 作者认为将绝对风险应用于特定人群可能需要重新校准。
研究设计与样本
- 前瞻性队列研究,分析UKB(n=395647,1651例)与MCCS(澳大利亚,n=4765,303例)中侵袭性黑色素瘤发病情况。
- 评估三种PRS:2020年荟萃分析54个位点68个SNP(PRS68)、排除UKB的2020年荟萃分析50个SNP(PRS50)、2018年已知21个位点45个SNP(PRS45)。
- 按年龄组和性别从人群癌症登记数据计算十年黑色素瘤风险,比较有与无PRS校正的情况。
主要发现
- 仅基于年龄和性别的预测绝对风险低估黑色素瘤发病率:UKB的E/O=0·65(95%CI 0·62-0·68),MCCS的E/O=0·63(95%CI 0·56-0·72)。
- UKB中PRS校正改善校准,PRS50校正风险E/O=0·91(95%CI 0·87-0·95)。
- PRS68与PRS50校正绝对风险的判别能力高于仅基于年龄和性别的风险(ΔAUC 0·07-0·10,P<0·0001),也高于PRS45校正风险(ΔAUC 0·02-0·04,P<0·001)。
关键数值与推荐
- UKB仅年龄性别模型E/O=0·65(95%CI 0·62-0·68),MCCS为E/O=0·63(95%CI 0·56-0·72)。
- UKB中PRS50校正风险E/O=0·91(95%CI 0·87-0·95)。
- PRS68与PRS50校正风险较年龄性别模型的ΔAUC为0·07-0·10(P<0·0001),较PRS45校正风险的ΔAUC为0·02-0·04(P<0·001)。
临床怎么用
- 作者认为基于更大、更多样化荟萃分析的PRS可能有助于按不同风险水平制定黑色素瘤预防和早期发现策略。
- 作者认为将绝对风险应用于特定人群可能需要重新校准。
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies suggest that polygenic risk scores (PRSs) may improve melanoma risk stratification. However, there has been limited independent validation of PRS-based risk prediction, particularly assessment of calibration (comparing predicted to observed risks). OBJECTIVES: To evaluate PRS-based melanoma risk prediction in prospective UK and Australian cohorts with European ancestry. METHODS: We analysed invasive melanoma incidence in the UK Biobank (UKB; n = 395 647, 1651 cases) and a case-cohort nested within the Melbourne Collaborative Cohort Study (MCCS, Australia; n = 4765, 303 cases). Three PRSs were evaluated: 68 single-nucleotide polymorphisms (SNPs) at 54 loci from a 2020 meta-analysis (PRS68), 50 SNPs significant in the 2020 meta-analysis excluding UKB (PRS50) and 45 SNPs at 21 loci known in 2018 (PRS45). Ten-year melanoma risks were calculated from population-level cancer registry data by age group and sex, with and without PRS adjustment. RESULTS: Predicted absolute melanoma risks based on age and sex alone underestimated melanoma incidence in the UKB [ratio of expected/observed cases: E/O = 0·65, 95% confidence interval (CI) 0·62-0·68] and MCCS (E/O = 0·63, 95% CI 0·56-0·72). For UKB, calibration was improved by PRS adjustment, with PRS50-adjusted risks E/O = 0·91, 95% CI 0·87-0·95. The discriminative ability for PRS68- and PRS50-adjusted absolute risks was higher than for risks based on age and sex alone (Δ area under the curve 0·07-0·10, P < 0·0001), and higher than for PRS45-adjusted risks (Δ area under the curve 0·02-0·04, P < 0·001). CONCLUSIONS: A PRS derived from a larger, more diverse meta-analysis improves risk prediction compared with an earlier PRS, and might help tailor melanoma prevention and early detection strategies to different risk levels. Recalibration of absolute risks may be necessary for application to specific populations.
引用
- Steinberg J, Iles MM, Lee JY, et al. Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts. Br J Dermatol. 2022. PMID: 34921685. doi:10.1111/bjd.20956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。